Loading...
01/10 16:58
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals several challenges: a revenue decline, cost inflation, backlog reduction, and deleveraging issues. Despite some positive developments like the TerraSource sale for debt reduction, the financial performance is weak, with a significant year-over-year decrease in revenue and adjusted EBITDA. The Q&A section highlights management's lack of clarity on tariffs and future orders, further contributing to uncertainty. Given these factors and the company's small-cap status, a negative stock price movement of -2% to -8% is expected.
Revenue $716,000,000, down 9% year-over-year due to reduced volume stemming from a lower starting backlog.
Adjusted EBITDA $99,000,000, decreased 19% year-over-year, primarily due to lower volume and cost inflation, despite productivity and favorable pricing.
Adjusted EBITDA Margin 13.8%, a decrease of 180 basis points year-over-year, largely due to the impact of lower volume on operating leverage.
GAAP Net Loss $41,000,000, down from income of $6,000,000 in the prior year due to a non-cash loss on the majority sale of Milacron.
Adjusted Earnings Per Share $0.60, decreased 21% year-over-year, but exceeded expectations due to favorable interest expense and other corporate items.
Adjusted Effective Tax Rate 30.9%, which was 280 basis points higher than the prior year due to geographic mix of income.
Cash Flow from Operations Approximately $1,000,000, consistent with the prior year, reflecting typical seasonality.
Capital Expenditures $9,000,000 in the quarter.
Shareholder Payments Approximately $60,000,000 paid through quarterly dividends.
Backlog $1,600,000,000, decreased 15% year-over-year due to increased macro uncertainty from tariffs.
MTS Revenue $222,000,000, decreased 2% year-over-year, largely due to unfavorable foreign exchange.
MTS Adjusted EBITDA $32,000,000, decreased 4% year-over-year due to cost inflation, partially offset by productivity.
MTS Adjusted EBITDA Margin 14.5%, down 40 basis points year-over-year.
Net Debt $1,460,000,000, with a net debt to pro forma adjusted EBITDA ratio of 3.4 times.
Proceeds from TerraSource Sale Expected net proceeds of approximately $100,000,000, which will be used to pay down debt.
Direct Tariff Costs Approximately $15,000,000 included in the updated outlook for the remainder of the year.
Operating Cash Flow Guidance Expected to be approximately $120,000,000.
CapEx Guidance Expected to be $40,000,000.
Revenue: Revenue of $716,000,000 was reported, down 9% compared to the prior year, primarily due to reduced volume stemming from a lower starting backlog.
Adjusted Earnings Per Share: Adjusted earnings per share of $0.60 decreased 21% versus the prior year, but exceeded expectations.
Backlog: Backlog of $1,600,000,000 decreased 15% compared to the prior year, largely stemming from increased macro uncertainty from tariffs.
Revenue Guidance: Updated guidance anticipates total revenue of approximately $2,560,000,000 to $2,620,000, down significantly from previous guidance.
Cost Control Initiatives: The company is focused on executing cost out initiatives, including cost controls and accelerated footprint consolidation.
Supply Chain Strategy: The supply chain strategy has evolved significantly since COVID, with a focus on regional demand to reduce exposure to tariffs.
Tariff Mitigation Actions: A comprehensive multi-pronged strategy is in place to mitigate tariff impacts, including alternative sourcing and adjusting contract terms.
Portfolio Transformation: The completion of the divestiture allows Hillenbrand to focus on core strengths in highly engineered, value-added processing technologies.
Market Positioning: Hillenbrand aims to leverage its expertise in systems design and process technology across diverse end markets, including food and health.
Divestiture of TerraSource: Entered into a definitive agreement to sell the TerraSource global business for $245,000,000, with expected net proceeds of approximately $100,000,000.
Global Macroeconomic Uncertainty: Demand heavily impacted by ongoing global macroeconomic uncertainty, leading to delays in customer investment plans.
Tariff Escalation: Significant escalation of tariffs has caused customers to pause larger investments and reevaluate contracts.
Customer Sentiment: Falling business and consumer confidence has resulted in a wait-and-see approach from customers.
Supply Chain Challenges: Higher costs of doing business due to tariffs and supply chain disruptions, with a portion of suppliers being international.
Financial Performance Impact: Expected revenue decline due to lower orders and macroeconomic pressures, with an updated outlook reflecting these challenges.
Cost Inflation: Cost inflation impacting adjusted EBITDA and overall financial performance.
Investment Delays: Customers postponing decisions until clarity on tariff policies and economic impacts is achieved.
Backlog Reduction: Backlog decreased significantly due to increased macro uncertainty, leading to weaker than expected orders.
Deleveraging Challenges: Despite asset sales, the path to deleverage remains challenged due to current economic conditions.
Pricing Pressure: Pricing power remains challenged in certain segments due to lower demand and competitive pressures.
Portfolio Update: Hillenbrand completed a 51% interest acquisition in the Milacron Injection Molding and Extrusion business, allowing a focus on core strengths in engineered processing technologies.
Market Focus: The company is concentrating on Performance Materials, including plastics and food, health, and nutrition markets, which are expected to grow due to long-term trends.
Cost Control Initiatives: Hillenbrand is executing cost control initiatives and accelerating footprint consolidation in response to market changes.
Supply Chain Strategy: The company has adapted its supply chain strategy to reduce exposure to tariffs and is actively managing global supply chain risks.
Synergy Achievements: Hillenbrand is on track to achieve synergies from acquisitions ahead of schedule, focusing on integration and operational efficiencies.
Revenue Guidance: Total revenue is now expected to be approximately $2.56 billion to $2.62 billion, down from previous guidance due to lower orders.
Adjusted EBITDA Guidance: Adjusted EBITDA is projected to be between $363 million and $395 million, reflecting lower revenue and direct tariff impacts.
Adjusted EPS Guidance: Adjusted earnings per share is now expected to be in the range of $2.10 to $2.45.
CapEx Guidance: Capital expenditures are expected to be approximately $40 million as the company prioritizes and defers spending.
Tariff Impact: The updated outlook includes an estimated $15 million impact from direct tariffs.
Quarterly Dividend Paid: $60,000,000 paid to shareholders through quarterly dividend.
Shareholder Return Plan: The company has entered into a definitive agreement to sell the TerraSource global business for $245,000,000, with expected net proceeds to Hillenbrand of approximately $100,000,000, which will be used to pay down debt.
The earnings call reveals several negative indicators: decreased revenue guidance, lower adjusted EBITDA, and a significant tariff impact. The Q&A highlights uncertainties in cash flow and leverage, with management avoiding clear guidance on dividends. Despite some positive developments in orders and demand, the overall sentiment is cautious due to declining margins and backlog, as well as a competitive pricing environment. Given the market cap, the stock is likely to experience a negative reaction in the range of -2% to -8%.
The earnings call revealed several concerning factors: a decline in revenue and EBITDA, a net loss, and a high net debt ratio. Despite some positive elements like the sale of TerraSource and achieving synergy targets, market volatility and tariff impacts are significant challenges. The Q&A highlighted order delays and management's lack of clarity on inflation impacts. The company's market cap suggests moderate sensitivity to these issues, leading to a predicted negative stock price movement of -2% to -8%.
The earnings call reveals several challenges: a revenue decline, cost inflation, backlog reduction, and deleveraging issues. Despite some positive developments like the TerraSource sale for debt reduction, the financial performance is weak, with a significant year-over-year decrease in revenue and adjusted EBITDA. The Q&A section highlights management's lack of clarity on tariffs and future orders, further contributing to uncertainty. Given these factors and the company's small-cap status, a negative stock price movement of -2% to -8% is expected.
The earnings call reveals declining financial performance, with year-over-year decreases in revenue, EPS, and EBITDA, compounded by geopolitical and economic uncertainties. Despite some positive updates, such as the Milacron sale proceeds and potential market strength in specific regions, the overall guidance reflects a downward trend. The Q&A section highlights management's evasive responses and ongoing market challenges, which could further dampen investor confidence. Given the company's market cap and the current negative sentiment, a negative stock price movement is anticipated over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
